NO166409C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.Info
- Publication number
- NO166409C NO166409C NO862487A NO862487A NO166409C NO 166409 C NO166409 C NO 166409C NO 862487 A NO862487 A NO 862487A NO 862487 A NO862487 A NO 862487A NO 166409 C NO166409 C NO 166409C
- Authority
- NO
- Norway
- Prior art keywords
- branched
- straight
- alkyl
- optionally substituted
- different
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Luminescent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21236/85A IT1222367B (it) | 1985-06-21 | 1985-06-21 | Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico |
Publications (4)
Publication Number | Publication Date |
---|---|
NO862487D0 NO862487D0 (no) | 1986-06-20 |
NO862487L NO862487L (no) | 1986-12-22 |
NO166409B NO166409B (no) | 1991-04-08 |
NO166409C true NO166409C (no) | 1991-07-24 |
Family
ID=11178826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO862487A NO166409C (no) | 1985-06-21 | 1986-06-20 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4703054A (no) |
EP (1) | EP0207680B1 (no) |
JP (1) | JPH0688979B2 (no) |
KR (1) | KR870000305A (no) |
AT (1) | ATE56020T1 (no) |
AU (1) | AU590283B2 (no) |
CA (1) | CA1273450A (no) |
DE (1) | DE3673709D1 (no) |
DK (1) | DK290386A (no) |
FI (1) | FI862422A (no) |
GR (1) | GR861578B (no) |
HU (1) | HUT41741A (no) |
IL (1) | IL79138A (no) |
IT (1) | IT1222367B (no) |
NO (1) | NO166409C (no) |
NZ (1) | NZ216552A (no) |
PH (2) | PH23229A (no) |
ZA (1) | ZA864446B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1209644B (it) * | 1985-06-21 | 1989-08-30 | Isf Spa | Composti farmacologicamente attivi. |
FR2677984B1 (fr) * | 1991-06-21 | 1994-02-25 | Elf Sanofi | Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant. |
JP2606026B2 (ja) * | 1991-07-09 | 1997-04-30 | コクヨ株式会社 | フォルダー |
WO2001053269A1 (en) * | 2000-01-18 | 2001-07-26 | The Regents Of The University Of California | Acid addition salts of imidazolidinones as reaction catalysts |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH449029A (de) * | 1963-08-12 | 1967-12-31 | Hoffmann La Roche | Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen |
IT1209644B (it) * | 1985-06-21 | 1989-08-30 | Isf Spa | Composti farmacologicamente attivi. |
-
1985
- 1985-06-21 IT IT21236/85A patent/IT1222367B/it active
-
1986
- 1986-06-06 FI FI862422A patent/FI862422A/fi not_active Application Discontinuation
- 1986-06-13 ZA ZA864446A patent/ZA864446B/xx unknown
- 1986-06-16 NZ NZ216552A patent/NZ216552A/xx unknown
- 1986-06-17 DE DE8686304650T patent/DE3673709D1/de not_active Expired - Lifetime
- 1986-06-17 IL IL79138A patent/IL79138A/xx unknown
- 1986-06-17 EP EP86304650A patent/EP0207680B1/en not_active Expired - Lifetime
- 1986-06-17 AT AT86304650T patent/ATE56020T1/de not_active IP Right Cessation
- 1986-06-18 GR GR861578A patent/GR861578B/el unknown
- 1986-06-20 CA CA000512111A patent/CA1273450A/en not_active Expired - Fee Related
- 1986-06-20 HU HU862610A patent/HUT41741A/hu unknown
- 1986-06-20 DK DK290386A patent/DK290386A/da not_active Application Discontinuation
- 1986-06-20 NO NO862487A patent/NO166409C/no unknown
- 1986-06-20 AU AU58917/86A patent/AU590283B2/en not_active Ceased
- 1986-06-20 PH PH33924A patent/PH23229A/en unknown
- 1986-06-20 JP JP61144688A patent/JPH0688979B2/ja not_active Expired - Lifetime
- 1986-06-20 US US06/876,946 patent/US4703054A/en not_active Expired - Lifetime
- 1986-06-20 KR KR1019860004922A patent/KR870000305A/ko not_active Application Discontinuation
-
1987
- 1987-08-20 PH PH35708A patent/PH24336A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0207680B1 (en) | 1990-08-29 |
NO862487D0 (no) | 1986-06-20 |
NO166409B (no) | 1991-04-08 |
PH23229A (en) | 1989-06-06 |
EP0207680A2 (en) | 1987-01-07 |
GR861578B (en) | 1986-10-21 |
IT1222367B (it) | 1990-09-05 |
CA1273450A (en) | 1990-08-28 |
NZ216552A (en) | 1989-11-28 |
AU590283B2 (en) | 1989-11-02 |
HUT41741A (en) | 1987-05-28 |
DK290386A (da) | 1987-02-11 |
NO862487L (no) | 1986-12-22 |
IT8521236A0 (it) | 1985-06-21 |
DK290386D0 (da) | 1986-06-20 |
EP0207680A3 (en) | 1989-01-18 |
FI862422A0 (fi) | 1986-06-06 |
US4703054A (en) | 1987-10-27 |
KR870000305A (ko) | 1987-02-17 |
JPS6230763A (ja) | 1987-02-09 |
DE3673709D1 (de) | 1990-10-04 |
JPH0688979B2 (ja) | 1994-11-09 |
PH24336A (en) | 1990-06-13 |
AU5891786A (en) | 1986-12-24 |
FI862422A (fi) | 1986-12-22 |
IL79138A (en) | 1991-04-15 |
ATE56020T1 (de) | 1990-09-15 |
ZA864446B (en) | 1987-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL74631A0 (en) | 3-substituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them | |
NO166409C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. | |
NO168428C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt pyrrolidonderivat | |
NO168173C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater |